Disproportionate Use of the ED by Patients 3 Years After e-Cigarette or Vaping Use-Associated Lung Injury.

Competing Interests: Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: Unrelated to e-cigarettes, J. J. R. is a cofounder of Omnibus Medical Devices and a shareholder, officer, and director of Globin Solutions outside of the submitted work. J. J. R. is a coinventor on patents and applications for the use of carbon monoxide scavenging molecules as therapies for carbon monoxide poisoning, licensed to Globin Solutions, which has a license for technologies that use nitrite as a therapy against cardiovascular disease from the National Institutes of Health and the University of Pittsburgh. J. J. R. is a coinventor on a patent application that is unlicensed for the use of nitrite as a treatment for halogen gas poisoning and fire smoke injuries. None declared (M. S. Z., T. N., M. L., A. M., D. C.).